About ViaNautis

ViaNautis transforms cell and gene therapy through its proprietary polyNaut nanovesicle platform. This modular, non-viral delivery system enables precise targeting of genetic therapeutics to cells in the central nervous system, lung, and immune system, overcoming biological barriers that have historically limited treatment options. The platform offers broad payload flexibility, good tolerability, and simplified scalable manufacturing. By making genetic therapies shelf-stable and re-dosable, ViaNautis expands access to safer, more practical treatments for patients with diseases that currently lack effective therapeutic solutions.